デフォルト表紙
市場調査レポート
商品コード
1318972

トランスレーショナル再生医療市場:製品タイプ、用途別-2023-2030年の世界予測

Translational Regenerative Medicine Market by Product Type, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 191 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
トランスレーショナル再生医療市場:製品タイプ、用途別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 191 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

トランスレーショナル再生医療の世界市場は大きく成長すると予測され、2023年には30億1,986万米ドルが予測され、CAGRは11.46%、2030年には64億6,247万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のトランスレーショナル再生医療市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.トランスレーショナル再生医療の世界市場規模および予測は?

2.予測期間中、世界のトランスレーショナル再生医療市場を形成するCOVID-19の阻害要因と影響は?

3.トランスレーショナル再生医療の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.トランスレーショナル再生医療の世界市場における競争戦略は?

5.トランスレーショナル再生医療の世界市場における技術動向と規制の枠組みは?

6.トランスレーショナル再生医療の世界市場における主要ベンダーの市場シェアは?

7.トランスレーショナル再生医療の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で慢性疾患や遺伝関連疾患の発生率が増加
      • がんや自閉症などの病気の治療のための幹細胞療法の需要の急増
      • 高齢者人口の増加と関連疾患
    • 抑制要因
      • 高額な治療費と業務の非効率性
    • 機会
      • 再生医療による臓器移植の調査が進行中
      • 有利な償還ポリシーと技術の進歩
    • 課題
      • 厳格な規制とコンプライアンスの承認義務
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 トランスレーショナル再生医療市場:製品タイプ別

  • 細胞ベースの製品
  • 遺伝子治療製品
  • 組織工学的に加工された製品

第7章 トランスレーショナル再生医療市場:用途別

  • 心臓血管
  • 皮膚科
  • 糖尿病
  • 神経内科
  • 腫瘍学
  • 整形外科

第8章 南北アメリカのトランスレーショナル再生医療市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のトランスレーショナル再生医療市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのトランスレーショナル再生医療市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. TRANSLATIONAL REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 5. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. TRANSLATIONAL REGENERATIVE MEDICINE MARKET DYNAMICS
  • FIGURE 8. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. TRANSLATIONAL REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL BASED PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE ENGINEERED PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. TRANSLATIONAL REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 102. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 103. TRANSLATIONAL REGENERATIVE MEDICINE MARKET LICENSE & PRICING
目次
Product Code: MRR-031685195780

The Global Translational Regenerative Medicine Market is forecasted to grow significantly, with a projected USD 3,019.86 million in 2023 at a CAGR of 11.46% and expected to reach a staggering USD 6,462.47 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Translational Regenerative Medicine Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Translational Regenerative Medicine Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product Type, market is studied across Cell Based Product, Gene Therapy Product, and Tissue Engineered Product. The Gene Therapy Product is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cardiovascular, Dermatology, Diabetes, Neurology, Oncology, and Orthopedic. The Neurology is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Translational Regenerative Medicine Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Translational Regenerative Medicine Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Translational Regenerative Medicine Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Translational Regenerative Medicine Market?

4. What is the competitive strategic window for opportunities in the Global Translational Regenerative Medicine Market?

5. What are the technology trends and regulatory frameworks in the Global Translational Regenerative Medicine Market?

6. What is the market share of the leading vendors in the Global Translational Regenerative Medicine Market?

7. What modes and strategic moves are considered suitable for entering the Global Translational Regenerative Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Translational Regenerative Medicine Market, by Product Type, 2022 vs 2030
  • 4.3. Translational Regenerative Medicine Market, by Application, 2022 vs 2030
  • 4.4. Translational Regenerative Medicine Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of chronic and genetic related diseases worldwide
      • 5.1.1.2. Upsurge in the demand for stem cell therapy for the treatment of diseases such as cancer and autism
      • 5.1.1.3. Rising geriatric population coupled with associated diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the treatment and operational inefficiency
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research in the organ transplantation with regenerative medicine
      • 5.1.3.2. Favorable reimbursement policies and technological advancements
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and compliance mandates for approval
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Translational Regenerative Medicine Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cell Based Product
  • 6.3. Gene Therapy Product
  • 6.4. Tissue Engineered Product

7. Translational Regenerative Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular
  • 7.3. Dermatology
  • 7.4. Diabetes
  • 7.5. Neurology
  • 7.6. Oncology
  • 7.7. Orthopedic

8. Americas Translational Regenerative Medicine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Translational Regenerative Medicine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Translational Regenerative Medicine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing